Cramer's lightning round: Allergan's in a torturous situation
September 11, 2017 at 18:51 PM EDT
Jim Cramer rattles off his take on callers' favorite stocks, including one hurting pharmaceutical name.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.